Judith A. James

Judith A. James's AcademicInfluence.com Rankings

Judith A. James

Medical

#3216

World Rank

#3674

Historical Rank

Rheumatology

#30

World Rank

#31

Historical Rank

medical Degrees

Download Badge

Medical

Why Is Judith A. James Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Judith A. James's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Development of autoantibodies before the clinical onset of systemic lupus erythematosus. (2003) (2233)
Rapid cloning of high-affinity human monoclonal antibodies against influenza virus (2008) (938)
An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. (1997) (497)
Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome 1q in African-American pedigrees. (1998) (481)
Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren’s syndrome (2013) (411)
Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry (2005) (382)
Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure. (2001) (362)
Dense genotyping of immune-related disease regions identifies 14 new susceptibility loci for juvenile idiopathic arthritis (2013) (337)
Human polymorphism at microRNAs and microRNA target sites. (2013) (330)
A nonsynonymous functional variant in integrin-αM (encoded by ITGAM) is associated with systemic lupus erythematosus (2008) (311)
Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus (2011) (267)
Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies. (2011) (254)
Transancestral mapping and genetic load in systemic lupus erythematosus (2017) (253)
Tubular Cell and Keratinocyte Single-cell Transcriptomics Applied to Lupus Nephritis Reveal Type I IFN and Fibrosis Relevant Pathways (2019) (244)
Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus (2006) (237)
Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort (2011) (231)
End‐Stage Renal Disease in African Americans With Lupus Nephritis Is Associated With APOL1 (2014) (226)
Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosus (2011) (217)
Network analysis of associations between serum interferon-α activity, autoantibodies, and clinical features in systemic lupus erythematosus. (2011) (210)
Genetic association of interleukin-21 polymorphisms with systemic lupus erythematosus (2007) (194)
Association of Genetic Variants in Complement Factor H and Factor H-Related Genes with Systemic Lupus Erythematosus Susceptibility (2011) (193)
Clinical criteria for systemic lupus erythematosus precede diagnosis, and associated autoantibodies are present before clinical symptoms. (2007) (191)
Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications (2020) (191)
Notch signaling drives synovial fibroblast identity and arthritis pathology (2020) (186)
Visualization of P-selectin Glycoprotein Ligand-1 as a Highly Extended Molecule and Mapping of Protein Epitopes for Monoclonal Antibodies (*) (1996) (185)
The prevalence, onset, and clinical significance of antiphospholipid antibodies prior to diagnosis of systemic lupus erythematosus. (2004) (173)
Haematological manifestations of lupus (2015) (172)
Altered type II interferon precedes autoantibody accrual and elevated type I interferon activity prior to systemic lupus erythematosus classification (2016) (171)
Identification of IRF8, TMEM39A, and IKZF3-ZPBP2 as susceptibility loci for systemic lupus erythematosus in a large-scale multiracial replication study. (2012) (159)
Identification of multiple genetic susceptibility loci in Takayasu arteritis. (2013) (144)
Common Variants within MECP2 Confer Risk of Systemic Lupus Erythematosus (2008) (142)
IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus (2011) (135)
Genome‐Wide DNA Methylation Study Identifies Significant Epigenomic Changes in Osteoarthritic Cartilage (2014) (135)
B‐cell epitope spreading in autoimmunity (1998) (132)
An altered immune response to Epstein-Barr nuclear antigen 1 in pediatric systemic lupus erythematosus. (2006) (128)
Aberrant Epstein-Barr viral infection in systemic lupus erythematosus. (2009) (128)
Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodies. (2016) (122)
Genome‐Wide Association Study in an Amerindian Ancestry Population Reveals Novel Systemic Lupus Erythematosus Risk Loci and the Role of European Admixture (2015) (122)
A polymorphism within IL21R confers risk for systemic lupus erythematosus. (2009) (121)
Identification of novel genetic susceptibility loci in African American lupus patients in a candidate gene association study. (2011) (119)
PD-1hi CXCR5- T peripheral helper cells promote B cells responses in lupus via MAF and IL-21. (2019) (118)
Phenotypic associations of genetic susceptibility loci in systemic lupus erythematosus (2011) (117)
Evaluation of imputation-based association in and around the integrin-alpha-M (ITGAM) gene and replication of robust association between a non-synonymous functional variant within ITGAM and systemic lupus erythematosus (SLE). (2009) (112)
Linear epitope mapping of an Sm B/B' polypeptide. (1992) (111)
New-onset IgG autoantibodies in hospitalized patients with COVID-19 (2021) (110)
Admixture Mapping in Lupus Identifies Multiple Functional Variants within IFIH1 Associated with Apoptosis, Inflammation, and Autoantibody Production (2013) (105)
Interferon regulatory factor-5 is genetically associated with systemic lupus erythematosus in African Americans (2008) (102)
Epstein-Barr virus infection induces lupus autoimmunity. (2006) (100)
Lupus and Epstein-Barr (2012) (100)
Modification of lupus-associated 60-kDa Ro protein with the lipid oxidation product 4-hydroxy-2-nonenal increases antigenicity and facilitates epitope spreading. (2005) (99)
MicroRNA-3148 Modulates Allelic Expression of Toll-Like Receptor 7 Variant Associated with Systemic Lupus Erythematosus (2013) (99)
The curiously suspicious: a role for Epstein-Barr virus in lupus (2006) (97)
X Chromosome Dose and Sex Bias in Autoimmune Diseases: Increased Prevalence of 47,XXX in Systemic Lupus Erythematosus and Sjögren's Syndrome (2015) (96)
Fine mapping of Xq28: both MECP2 and IRAK1 contribute to risk for systemic lupus erythematosus in multiple ancestral groups (2012) (95)
Regulatory polymorphisms modulate the expression of HLA class II molecules and promote autoimmunity (2016) (95)
Lupus-like autoantibody development in rabbits and mice after immunization with EBNA-1 fragments. (2008) (92)
Analysis of autosomal genes reveals gene–sex interactions and higher total genetic risk in men with systemic lupus erythematosus (2011) (89)
Identification of a systemic lupus erythematosus susceptibility locus at 11p13 between PDHX and CD44 in a multiethnic study. (2011) (88)
High-density genotyping of STAT4 reveals multiple haplotypic associations with systemic lupus erythematosus in different racial groups. (2009) (88)
Meta-analysis and Imputation Identifies a 109 kb Risk Haplotype Spanning TNFAIP3 Associated with Lupus Nephritis and Hematologic Manifestations (2009) (85)
Immunodominance of Antigenic Site B over Site A of Hemagglutinin of Recent H3N2 Influenza Viruses (2012) (85)
ITGAM coding variant (rs1143679) influences the risk of renal disease, discoid rash and immunological manifestations in patients with systemic lupus erythematosus with European ancestry (2009) (84)
Genetic associations of LYN with systemic lupus erythematosus (2009) (81)
Impact of genetic ancestry and sociodemographic status on the clinical expression of systemic lupus erythematosus in American Indian-European populations. (2012) (81)
Human B cell subsets. (2008) (80)
Variants within MECP2, a key transcription regulator, are associated with increased susceptibility to lupus and differential gene expression in patients with systemic lupus erythematosus. (2009) (80)
A model of peptide-induced lupus autoimmune B cell epitope spreading is strain specific and is not H-2 restricted in mice. (1998) (80)
Proinflammatory Adaptive Cytokine and Shed Tumor Necrosis Factor Receptor Levels Are Elevated Preceding Systemic Lupus Erythematosus Disease Flare (2014) (79)
The intersection of COVID-19 and autoimmunity. (2021) (79)
Osteopontin and Systemic Lupus Erythematosus Association: A Probable Gene-Gender Interaction (2008) (78)
IgH sequences in common variable immune deficiency reveal altered B cell development and selection (2015) (77)
The genetics of systemic lupus erythematosus stratified by renal disease: linkage at 10q22.3 (SLEN1), 2q34-35 (SLEN2), and 11p15.6 (SLEN3) (2002) (76)
The lupus family registry and repository. (2011) (75)
Autoantibody‐Positive Healthy Individuals Display Unique Immune Profiles That May Regulate Autoimmunity (2016) (75)
Genetic and physical interaction of the B-cell systemic lupus erythematosus-associated genes BANK1 and BLK (2011) (74)
Primary Sjogren's syndrome: current and prospective therapies. (2008) (73)
Large-scale analysis of tumor necrosis factor α levels in systemic lupus erythematosus. (2012) (72)
Association of two independent functional risk haplotypes in TNIP1 with systemic lupus erythematosus. (2012) (72)
ABIN1 dysfunction as a genetic basis for lupus nephritis. (2013) (70)
Recent Advances and Opportunities in Research on Lupus: Environmental Influences and Mechanisms of Disease (2008) (70)
Methods for high-dimensonal analysis of cells dissociated from cyropreserved synovial tissue (2018) (69)
Lupus Humoral Autoimmunity after Short Peptide Immunization a (1997) (69)
Anti-Sm Autoantibodies in Systemic Lupus Target Highly Basic Surface Structures of Complexed Spliceosomal Autoantigens1 (2002) (68)
Comparison of autoantibody specificities between traditional and bead-based assays in a large, diverse collection of patients with systemic lupus erythematosus and family members. (2012) (68)
Clostridium difficile 027/BI/NAP1 Encodes a Hypertoxic and Antigenically Variable Form of TcdB (2013) (68)
The IRF5-TNPO3 association with systemic lupus erythematosus has two components that other autoimmune disorders variably share. (2014) (67)
Rapid clinical progression to diagnosis among African-American men with systemic lupus erythematosus (2003) (66)
Resequencing Study Confirms Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis. (2019) (66)
Autoantibody prevalence and lupus characteristics in a unique African American population. (2008) (65)
Epitope Mapping Using the X-Ray Crystallographic Structure of Complement Receptor Type 2 (CR2)/CD21: Identification of a Highly Inhibitory Monoclonal Antibody That Directly Recognizes the CR2-C3d Interface1 (2001) (64)
Evidence for gene-gene epistatic interactions among susceptibility loci for systemic lupus erythematosus. (2012) (63)
B lymphocyte stimulator levels in systemic lupus erythematosus: higher circulating levels in African American patients and increased production after influenza vaccination in patients with low baseline levels. (2011) (63)
Immunization of mice with human 60-kd Ro peptides results in epitope spreading if the peptides are highly homologous between human and mouse. (1999) (62)
Epstein–Barr virus and systemic lupus erythematosus (2006) (62)
Familial aggregation and linkage analysis of autoantibody traits in pedigrees multiplex for systemic lupus erythematosus (2006) (61)
Evaluation of genetic association between an ITGAM non-synonymous SNP (rs1143679) and multiple autoimmune diseases. (2012) (60)
Two functional lupus-associated BLK promoter variants control cell-type- and developmental-stage-specific transcription. (2014) (60)
Allelic heterogeneity in NCF2 associated with systemic lupus erythematosus (SLE) susceptibility across four ethnic populations. (2014) (59)
Influenza vaccination responses in human systemic lupus erythematosus: impact of clinical and demographic features. (2011) (59)
PTPN22 Association in Systemic Lupus Erythematosus (SLE) with Respect to Individual Ancestry and Clinical Sub-Phenotypes (2013) (58)
Trans-Ancestral Studies Fine Map the SLE-Susceptibility Locus TNFSF4 (2013) (58)
Variation in the ICAM1–ICAM4–ICAM5 locus is associated with systemic lupus erythematosus susceptibility in multiple ancestries (2012) (57)
Role of MYH9 and APOL1 in African and non-African populations with lupus nephritis (2011) (57)
Sequential autoantigenic determinants of the small nuclear ribonucleoprotein Sm D shared by human lupus autoantibodies and MRL Ipr/lpr antibodies (1994) (56)
The Role of Genetic Variation Near Interferon-Kappa in Systemic Lupus Erythematosus (2010) (56)
Functional characterization of the MECP2/IRAK1 lupus risk haplotype in human T cells and a human MECP2 transgenic mouse. (2013) (54)
A functional haplotype of UBE2L3 confers risk for systemic lupus erythematosus (2012) (54)
Fine-mapping and transethnic genotyping establish IL2/IL21 genetic association with lupus and localize this genetic effect to IL21. (2011) (54)
60 kD Ro and nRNP A Frequently Initiate Human Lupus Autoimmunity (2010) (53)
Evaluation of the genetic association of the PTPN22 R620W polymorphism in familial and sporadic systemic lupus erythematosus. (2006) (53)
Antibody quantity versus quality after influenza vaccination. (2009) (52)
Herpes Zoster Vaccination in SLE: A Pilot Study of Immunogenicity (2013) (52)
Enhancer histone-QTLs are enriched on autoimmune risk haplotypes and influence gene expression within chromatin networks (2018) (52)
Identification of a Sjögren's syndrome susceptibility locus at OAS1 that influences isoform switching, protein expression, and responsiveness to type I interferons (2017) (52)
Evaluation of TRAF6 in a large multiancestral lupus cohort. (2012) (51)
Replication of the BANK1 genetic association with systemic lupus erythematosus in a European-derived population (2009) (49)
Infectious mononucleosis patients temporarily recognize a unique, cross‐reactive epitope of Epstein‐Barr virus nuclear antigen‐1 (2003) (49)
Genome‐Wide DNA Methylation Study Identifies Significant Epigenomic Changes in Osteoarthritic Subchondral Bone and Similarity to Overlying Cartilage (2016) (49)
Epstein-Barr virus infection may be an environmental risk factor for systemic lupus erythematosus in children and teenagers. (1999) (49)
Ribosomal P autoantibodies are present before SLE onset and are directed against non-C-terminal peptides (2010) (49)
Association of Epstein-Barr virus serological reactivation with transitioning to systemic lupus erythematosus in at risk individuals (2019) (47)
Which outcome measures in SLE clinical trials best reflect medical judgment? (2014) (47)
Overlapping Features of Thrombotic Thrombocytopenic Purpura and Systemic Lupus Erythematosus (2007) (47)
Discerning Risk of Disease Transition in Relatives of Systemic Lupus Erythematosus Patients Utilizing Soluble Mediators and Clinical Features (2017) (46)
Epstein-Barr virus, cytomegalovirus, and multiple sclerosis susceptibility (2017) (46)
Genome scan stratified by the presence of anti-double-stranded DNA (dsDNA) autoantibody in pedigrees multiplex for systemic lupus erythematosus (SLE) establishes linkages at 19p13.2 (SLED1) and 18q21.1 (SLED2) (2002) (46)
Preferential Binding to Elk-1 by SLE-Associated IL10 Risk Allele Upregulates IL10 Expression (2013) (44)
Evaluation of C1q genomic region in minority racial groups of lupus (2009) (44)
Vitamin D status and antibody levels to common viruses in pediatric-onset multiple sclerosis (2011) (42)
Genetics of Lupus Nephritis: Clinical Implications. (2015) (42)
Select human anthrax protective antigen epitope-specific antibodies provide protection from lethal toxin challenge. (2010) (41)
The role of Epstein-Barr virus in systemic lupus erythematosus. (2001) (41)
Stratification of pedigrees multiplex for systemic lupus erythematosus and for self-reported rheumatoid arthritis detects a systemic lupus erythematosus susceptibility gene (SLER1) at 5p15.3. (2002) (40)
Association of PPP2CA polymorphisms with systemic lupus erythematosus susceptibility in multiple ethnic groups. (2011) (40)
The Biomarkers of Lupus Disease Study: A Bold Approach May Mitigate Interference of Background Immunosuppressants in Clinical Trials (2017) (39)
Vitamin D Deficiency in a Multiethnic Healthy Control Cohort and Altered Immune Response in Vitamin D Deficient European-American Healthy Controls (2014) (39)
A genome screen of systemic lupus erythematosus using affected-relative-pair linkage analysis with covariates demonstrates genetic heterogeneity (2002) (39)
Lupus Risk Variant Increases pSTAT1 Binding and Decreases ETS1 Expression. (2015) (38)
Differential expression of immunomodulatory galectin-1 in peripheral leukocytes and adult tissues and its cytosolic organization in striated muscle. (2010) (38)
Combined role of vitamin D status and CYP24A1 in the transition to systemic lupus erythematosus (2016) (37)
Human lupus anti-spliceosome A protein autoantibodies bind contiguous surface structures and segregate into two sequential epitope binding patterns. (1996) (37)
Induction of autoimmunity by multivalent immunodominant and subdominant T cell determinants of La (SS-B). (1999) (35)
Unique Sjögren's syndrome patient subsets defined by molecular features. (2020) (35)
Genetic fine mapping of systemic lupus erythematosus MHC associations in Europeans and African Americans (2018) (35)
Pathways of impending disease flare in African-American systemic lupus erythematosus patients. (2017) (34)
Biomarkers in connective tissue diseases (2017) (33)
Anti-Peptidoglycan Antibodies and Fcγ Receptors Are the Key Mediators of Inflammation in Gram-Positive Sepsis (2012) (33)
The sepsis model: an emerging hypothesis for the lethality of inhalation anthrax (2013) (33)
High Affinity Antibodies against Influenza Characterize the Plasmablast Response in SLE Patients After Vaccination (2015) (33)
Peptide Mimics of a Major Lupus Epitope of SmB/B′ (2003) (33)
Antibody response to common viruses and human leukocyte antigen-DRB1 in pediatric multiple sclerosis (2013) (33)
How should lupus flares be measured? Deconstruction of the safety of estrogen in lupus erythematosus national assessment-systemic lupus erythematosus disease activity index flare index. (2014) (33)
Polymorphisms in the Hsp70 gene locus are genetically associated with systemic lupus erythematosus (2010) (33)
Recent advances and opportunities in research on lupus: environmental influences and mechanisms of disease. (2009) (33)
Lupus risk variants in the PXK locus alter B-cell receptor internalization (2015) (31)
Adults with systemic lupus exhibit distinct molecular phenotypes in a cross-sectional study (2020) (31)
Use of SLICC criteria in a large, diverse lupus registry enables SLE classification of a subset of ACR-designated subjects with incomplete lupus (2017) (31)
Fully human monoclonal antibodies from antibody secreting cells after vaccination with Pneumovax®23 are serotype specific and facilitate opsonophagocytosis. (2013) (31)
Mycophenolate mofetil reduces STAT3 phosphorylation in systemic lupus erythematosus patients. (2019) (31)
Epstein Barr Virus and Autoimmune Responses in Systemic Lupus Erythematosus (2021) (31)
Site-1 protease deficiency causes human skeletal dysplasia due to defective inter-organelle protein trafficking. (2018) (30)
Early targets of nuclear RNP humoral autoimmunity in human systemic lupus erythematosus. (2009) (30)
Antigenicity of a recombinant Ro (SS-A) fusion protein. (1990) (30)
Impact of heart rate variability, a marker for cardiac health, on lupus disease activity (2016) (30)
Prolidase deficiency breaks tolerance to lupus‐associated antigens (2013) (30)
Clinical Efficacy and Safety of Baminercept, a Lymphotoxin &bgr; Receptor Fusion Protein, in Primary Sjögren's Syndrome: Results From a Phase II Randomized, Double‐Blind, Placebo‐Controlled Trial (2018) (29)
Preclinical systemic lupus erythematosus. (2014) (29)
Complement receptor 2 polymorphisms associated with systemic lupus erythematosus modulate alternative splicing (2009) (29)
Autoepitopes in lupus. (1995) (29)
Epstein Barr Virus Interleukin 10 Suppresses Anti-inflammatory Phenotype in Human Monocytes (2018) (28)
Sequential B-Cell Epitopes of Bacillus anthracis Lethal Factor Bind Lethal Toxin-Neutralizing Antibodies (2008) (28)
Preclinical lupus (2015) (28)
Clinical and Serologic Features in Patients With Incomplete Lupus Classification Versus Systemic Lupus Erythematosus Patients and Controls (2017) (28)
Fine specificity mapping of autoantigens targeted by anti-centromere autoantibodies. (2006) (28)
Clinical Efficacy and Safety of Baminercept, a Lymphotoxin β Receptor Fusion Protein, in Primary Sjögren's Syndrome (2018) (27)
Structural availability influences the capacity of autoantigenic epitopes to induce a widespread lupus-like autoimmune response. (2004) (27)
Epstein Barr virus nuclear antigen 1 (EBNA-1) peptides recognized by adult multiple sclerosis patient sera induce neurologic symptoms in a murine model. (2020) (27)
Strong viral associations with SLE among Filipinos (2017) (27)
Anthrax vaccination induced anti-lethal factor IgG: fine specificity and neutralizing capacity. (2011) (27)
Multiple Autoantibodies Display Association with Lymphopenia, Proteinuria, and Cellular Casts in a Large, Ethnically Diverse SLE Patient Cohort (2012) (27)
Peptide autoantigenicity of the small nuclear ribonucleoprotein C. (1995) (26)
Antibody‐Secreting Cell Specificity in Labial Salivary Glands Reflects the Clinical Presentation and Serology in Patients With Sjögren's Syndrome (2014) (26)
Lupus humoral autoimmunity induced in a primate model by short peptide immunization. (1998) (26)
Human monoclonal antibodies generated following vaccination with AVA provide neutralization by blocking furin cleavage but not by preventing oligomerization. (2012) (26)
Complement receptor 2 polymorphisms associated with systemic lupus erythematosus modulate alternative splicing (2009) (26)
Study of Anti-Malarials in Incomplete Lupus Erythematosus (SMILE): study protocol for a randomized controlled trial (2018) (26)
Development and validation of a simple lupus severity index using ACR criteria for classification of SLE (2016) (26)
Less than 7 hours of sleep per night is associated with transitioning to systemic lupus erythematosus (2018) (25)
Human effector B lymphocytes express ARID3a and secrete interferon alpha. (2016) (25)
Key developmental transitions in human germinal center B cells are revealed by differential CD45RB expression. (2009) (25)
Immunization with vesicular stomatitis virus nucleocapsid protein induces autoantibodies to the 60 kD Ro ribonucleoprotein particle. (1995) (25)
Accumulation of Antigen‐Driven Lymphoproliferations in Complement Receptor 2/CD21−/low B Cells From Patients With Sjögren's Syndrome (2018) (23)
A plausibly causal functional lupus-associated risk variant in the STAT1–STAT4 locus (2018) (22)
A limited lupus anti-spliceosomal response targets a cross-reactive, proline-rich motif. (1998) (22)
Notch signalling drives synovial fibroblast identity and arthritis pathology (2020) (22)
Association of Systemic Lupus Erythematosus With Uranium Exposure in a Community Living Near a Uranium‐Processing Plant: A Nested Case–Control Study (2014) (21)
Brief Report: Patients With Primary Sjögren's Syndrome Who Are Positive for Autoantibodies to Tripartite Motif–Containing Protein 38 Show Greater Disease Severity (2016) (20)
Protective environmental factors for neuromyelitis optica (2014) (20)
Genetic association of CD247 (CD3ζ) with SLE in a large-scale multiethnic study (2015) (20)
Autoantibody-positive healthy individuals with lower lupus risk display a unique immune endotype. (2020) (19)
The Major Neutralizing Antibody Responses to Recombinant Anthrax Lethal and Edema Factors Are Directed to Non-Cross-Reactive Epitopes (2009) (19)
Latent autoimmunity across disease-specific boundaries in at-risk first-degree relatives of SLE and RA patients (2019) (19)
Delineation of the Human Systemic Lupus Erythematosus Anti-Smith Antibody Response Using Phage-Display Combinatorial Libraries1 (2000) (19)
Prognostic significance of repeat biopsy in lupus nephritis: Histopathologic worsening and a short time between biopsies is associated with significantly increased risk for end stage renal disease and death. (2017) (18)
Anti‐neutrophil cytoplasmic antibodies target sequential functional proteinase 3 epitopes in the sera of patients with Wegener's granulomatosis (2010) (18)
Heterogeneity in association of remote herpesvirus infections and pediatric MS (2018) (18)
Novel genetic associations with interferon in systemic lupus erythematosus identified by replication and fine-mapping of trait-stratified genome-wide screen. (2020) (18)
Insights From Analysis of Human Antigen-Specific Memory B Cell Repertoires (2019) (18)
Disease Activity in Systemic Lupus Erythematosus Correlates With Expression of the Transcription Factor AT‐Rich–Interactive Domain 3A (2014) (18)
Antibodies to periodontogenic bacteria are associated with higher disease activity in lupus patients. (2019) (17)
Epitope specificity of myeloperoxidase antibodies: identification of candidate human immunodominant epitopes (2011) (17)
Top-down Mass Spectrometry Analysis of Human Serum Autoantibody Antigen-Binding Fragments (2019) (17)
Large Scale Analysis of Tumor Necrosis Factor Alpha Levels in Systemic Lupus Erythematosus (2012) (16)
Lethal factor antibodies contribute to lethal toxin neutralization in recipients of anthrax vaccine precipitated. (2017) (16)
Everyone comes from somewhere: systemic lupus erythematosus and Epstein-Barr virus induction of host interferon and humoral anti-Epstein-Barr nuclear antigen 1 immunity. (2010) (16)
Immunization with Peptides from 60 kDa Ro in Diverse Mouse Strains (2002) (16)
A highlight from the LUPUS 2014 meeting: eight great ideas (2015) (16)
Rheumatic Disease Among Oklahoma Tribal Populations: A Cross-sectional Study (2012) (16)
Autoimmunity as a Result of Escape from RNA Surveillance1 (2006) (16)
Epitope analysis of the major reactive region of the 100-kd protein of PM-Scl autoantigen. (1996) (15)
Side-chain specificities and molecular modelling of peptide determinants for two anti-Sm B/B' autoantibodies. (1999) (15)
Familial Aggregation of High Tumor Necrosis Factor Alpha Levels in Systemic Lupus Erythematosus (2013) (15)
Autoantibodies against Neurologic Antigens in Nonneurologic Autoimmunity (2019) (15)
ARID3a gene profiles are strongly associated with human interferon alpha production. (2019) (14)
Genetic Association of a Gain‐of‐Function IFNGR1 Polymorphism and the Intergenic Region LNCAROD/DKK1 With Behçet’s Disease (2021) (14)
Scoring systemic lupus erythematosus (SLE) disease activity with simple, rapid outcome measures (2019) (14)
Decreased SMG7 expression associates with lupus-risk variants and elevated antinuclear antibody production (2016) (14)
Immunologic findings precede rapid lupus flare after transient steroid therapy (2019) (14)
Preferential association of a functional variant in complement receptor 2 with antibodies to double-stranded DNA (2014) (14)
X chromosome dose and sex bias in autoimmune diseases: increased 47,XXX in systemic lupus erythematosus and Sjögren’s syndrome (BA4P.211) (2014) (13)
A common autoepitope near the carboxyl terminus of the 60-kD Ro ribonucleoprotein: Sequence similarity with a viral protein (1991) (13)
Anti-Ro and anti-nRNP response in unaffected family members of SLE patients. (2003) (13)
Anthrax Vaccine Precipitated Induces Edema Toxin-Neutralizing, Edema Factor-Specific Antibodies in Human Recipients (2017) (13)
Antigen nature and complexity influence human antibody light chain usage and specificity. (2016) (13)
Male-only Systemic Lupus (2010) (13)
Unique clinical characteristics, autoantibodies and medication use in Native American patients with systemic lupus erythematosus (2018) (12)
Impact of glucocorticoids on the incidence of lupus-related major organ damage: a systematic literature review and meta-regression analysis of longitudinal observational studies (2021) (12)
Effects of IRF5 Lupus Risk Haplotype on Pathways Predicted to Influence B Cell Functions (2012) (12)
Urine Proteomics and Renal Single‐Cell Transcriptomics Implicate Interleukin‐16 in Lupus Nephritis (2021) (12)
Humoral Antigenic Targets of the Ribosomal P0 Lupus Autoantigen Are Not Limited to the Carboxyl Region (2005) (12)
Genetic associations of LYN with systemic lupus erythematosus (2010) (12)
B-Cell and Monocyte Contribution to Systemic Lupus Erythematosus Identified by Cell-Type-Specific Differential Expression Analysis in RNA-Seq Data (2015) (12)
Cellular deconstruction of inflamed synovium defines diverse inflammatory phenotypes in rheumatoid arthritis (2022) (12)
the Clinical Efficacy and Safety of Baminercept, a Lymphotoxin-beta Receptor Fusion Protein, in Primary Sjögren's Syndrome: Results from a Randomized, Double-blind, Placebo-controlled Phase Ii Trial : abstract Number: 3203 (2015) (12)
Trans-Ethnic Mapping of BANK1 Identifies Two Independent SLE-Risk Linkage Groups Enriched for Co-Transcriptional Splicing Marks (2018) (11)
Differential Expression of the Transcription Factor ARID3a in Lupus Patient Hematopoietic Progenitor Cells (2015) (11)
Variable Association of Reactive Intermediate Genes with Systemic Lupus Erythematosus in Populations with Different African Ancestry (2013) (10)
Genetic associations of leptin-related polymorphisms with systemic lupus erythematosus. (2015) (10)
Memory B Cells Encode Neutralizing Antibody Specific for Toxin B from the Clostridium difficile Strains VPI 10463 and NAP1/BI/027 but with Superior Neutralization of VPI 10463 Toxin B (2015) (10)
Humoral responses to independent vaccinations are correlated in healthy boosted adults. (2014) (9)
Epstein-Barr Functional Mimicry: Pathogenicity of Oncogenic Latent Membrane Protein-1 in Systemic Lupus Erythematosus and Autoimmunity (2021) (9)
Immunization as a model for systemic lupus erythematosus. (1999) (9)
Influenza A (H1N1) virus infection triggers severe pulmonary inflammation in lupus-prone mice following viral clearance. (2015) (9)
Serologic markers of Epstein-Barr virus reactivation are associated with increased disease activity, inflammation, and interferon pathway activation in patients with systemic lupus erythematosus (2021) (9)
Clinical perspectives on lupus genetics: advances and opportunities. (2014) (9)
Immune Response to Enterococcus gallinarum in Lupus Patients Is Associated With a Subset of Lupus-Associated Autoantibodies (2021) (9)
Accelerating Medicines Partnership: Organizational Structure and Preliminary Data From the Phase 1 Studies of Lupus Nephritis (2020) (9)
Antibody Responses to Epstein‐Barr Virus in the Preclinical Period of Rheumatoid Arthritis Suggest the Presence of Increased Viral Reactivation Cycles (2021) (9)
Lupus autoantibodies recognize the product of an alternative open reading frame of SmB/B'. (2001) (8)
Anti‐U1A monoclonal antibodies recognize unique epitope targets of U1A which are involved in the binding of U1 RNA (2002) (8)
Association of IFIH1 and pro-inflammatory mediators: Potential new clues in SLE-associated pathogenesis (2017) (8)
Protective Antigen-Specific Memory B Cells Persist Years after Anthrax Vaccination and Correlate with Humoral Immunity (2014) (8)
MHC Class II and Non-MHC Class II Genes Differentially Influence Humoral Immunity to Bacillus anthracis Lethal Factor and Protective Antigen (2012) (8)
The promise of precision medicine in rheumatology (2022) (8)
Implications of a Vasodilatory Human Monoclonal Autoantibody in Postural Hypotension* (2013) (8)
Thrombotic Thrombocytopenic Purpura (TTP) and Systemic Lupus Erythematosus (SLE): Distinct but Potentially Overlapping Syndromes. (2004) (8)
Autoimmune hepatitis in the Alaska Native population: autoantibody profile and HLA associations (2014) (7)
Expression and methylation data from SLE patient and healthy control blood samples subdivided with respect to ARID3a levels (2016) (7)
Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry (2019) (7)
FRI0176 PHASE 2, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF A REVERSIBLE B CELL INHIBITOR, XMAB®5871, IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) (2019) (7)
Screening characteristics for enrichment of individuals at higher risk for transitioning to classified SLE (2019) (7)
Bacillus anthracis Edema Toxin Inhibits Efferocytosis in Human Macrophages and Alters Efferocytic Receptor Signaling (2019) (7)
Individual Antibody and T Cell Responses to Vaccination and Infection with the 2009 Pandemic Swine-Origin H1N1 Influenza Virus (2011) (7)
Shared and unique immune alterations in pre-clinical autoimmunity. (2019) (7)
Associations Between Smoking and Systemic Lupus Erythematosus–Related Cytokines and Chemokines Among US Female Nurses (2020) (7)
Lupus patient decisions about clinical trial participation: a qualitative evaluation of perceptions, facilitators and barriers (2020) (7)
Deep sequencing reveals a DAP1 regulatory haplotype that potentiates autoimmunity in systemic lupus erythematosus (2020) (6)
A polymorphism within interleukin-21 receptor (IL21R) confers risk for systemic lupus erythematosus and is associated with malar rash in lupus patients (49.17) (2009) (6)
Safety of procuring research tissue during a clinically indicated kidney biopsy from patients with lupus: data from the Accelerating Medicines Partnership RA/SLE Network (2021) (6)
FRI0003 Determination of interferon (IFN) signatures for sle patients may be critical for optimal treatment selection but depends on the genes chosen: report from the bold (biomarkers of lupus disease) study (2013) (6)
Stochastic humoral immunity to Bacillus anthracis protective antigen: identification of anti-peptide IgG correlating with seroconversion to Lethal Toxin neutralization. (2013) (6)
Multiple Sclerosis Is Rare in Epstein–Barr Virus–Seronegative Children with Central Nervous System Inflammatory Demyelination (2021) (6)
Human C. difficile toxin–specific memory B cell repertoires encode poorly neutralizing antibodies (2020) (6)
Toxin-neutralizing antibodies elicited by naturally acquired cutaneous anthrax are elevated following severe disease and appear to target conformational epitopes (2020) (6)
OP0020 Identification of Multiple Sjögren’s Syndrome Susceptibility Loci (2013) (6)
Anthrax Lethal Toxin-Induced Gene Expression Changes in Mouse Lung (2011) (6)
Evidence of Alternative Modes of B Cell Activation Involving Acquired Fab Regions of N‐Glycosylation in Antibody‐Secreting Cells Infiltrating the Labial Salivary Glands of Patients With Sjögren’s Syndrome (2018) (5)
Genome-wide association study identifies Sjögren’s risk loci with functional implications in immune and glandular cells (2022) (5)
ARID3a expression in human hematopoietic stem cells is associated with distinct gene patterns in aged individuals (2020) (5)
T Cell Mediated Conversion of a Non-Anti-La Reactive B Cell to an Autoreactive Anti-La B Cell by Somatic Hypermutation † (2021) (5)
Systemic lupus erythematosus (SLE) and chromosome 16: confirmation of linkage to 16q12–13 and evidence for genetic heterogeneity (2004) (5)
Modular gene analysis reveals distinct molecular signatures for cutaneous lupus patient subsets. (2021) (5)
Associations between daily alcohol consumption and systemic lupus erythematosus-related cytokines and chemokines among US female nurses without SLE (2020) (5)
OR.81Genetic Association of IL-21 Polymorphisms with Systemic Lupus Erythematosus (2007) (5)
A Genome-Wide Association Study Establishes Muliple Susceptibility Loci for Sjogren's Syndrome (2012) (5)
Update in rheumatoid arthritis therapy. (2005) (4)
Two Be or Not Two Be: The Nuclear Autoantigen La/SS-B Is Able to Form Dimers and Oligomers in a Redox Dependent Manner (2021) (4)
Sex Bias In Autoimmune Diseases : Increased Risk Of 47,XXX In Systemic Lupus Erythematosus (SLE) and Sjogren's Syndrome (SS) Supports The Gene Dose Hypothesis (2013) (4)
Unique Inflammatory Mediators and Specific IgE Levels Distinguish Local from Systemic Reactions after Anthrax Vaccine Adsorbed Vaccination (2016) (4)
Cell-bound complement activation products associate with lupus severity in SLE (2020) (4)
Impact of clinical and demographic features in influenza vaccination responses in human systemic lupus erythematosus (99.38) (2009) (4)
SAT0187 DISCRIMINATION OF SYSTEMIC LUPUS (SLE) PATIENTS WITH CLINICAL RESPONSE TO OBEXELIMAB (XMAB®5871) BASED ON A PATTERN OF IMMUNOLOGIC MARKERS (2020) (4)
Antiviral immune response in patients with multiple sclerosis, healthy siblings and twins (2010) (4)
Evidence of Dynamically Dysregulated Gene Expression Pathways in Hyperresponsive B Cells from African American Lupus Patients (2013) (4)
And Yet It Moves: Oxidation of the Nuclear Autoantigen La/SS-B Is the Driving Force for Nucleo-Cytoplasmic Shuttling (2021) (4)
Modular gene analysis reveals distinct molecular signatures for subsets of patients with cutaneous lupus erythematosus * (2021) (4)
Variants within MECP2 , a key transcriptional regulator, are associated with increased susceptibility to lupus and differential gene expression in lupus patients (2011) (3)
Disease activity in lupus correlates with expression of the transcription factor ARID3a (BA2P.119) (2014) (3)
Ribosomal and Immune Transcripts Associate with Relapse in Acquired ADAMTS13-Deficient Thrombotic Thrombocytopenic Purpura (2015) (3)
Author Correction: Genome-wide association study identifies Sjögren’s risk loci with functional implications in immune and glandular cells (2022) (3)
A High Prevalence of Anti-EBNA1 Heteroantibodies in Systemic Lupus Erythematosus (SLE) Supports Anti-EBNA1 as an Origin for SLE Autoantibodies (2022) (3)
MS is rare in EBV-seronegative children with CNS inflammatory demyelination. (2021) (3)
Lupus Susceptibility Region Containing CDKN1B rs34330 Mechanistically Influences Expression and Function of Multiple Target Genes, Also Linked to Proliferation and Apoptosis (2021) (3)
Antinuclear antibodies in general population: what does that mean? (P4535) (2013) (3)
THU0046 Predictive Modeling of Immunologic and Inflammatory Markers of Impending Disease Flare in Patients with Systemic Lupus Erythematosus not Taking Immunosuppressive Medications (2014) (3)
New perspectives and insights to Asian systemic lupus erythematosus: renal disease, genetic predisposition and disease activity (2013) (3)
Hydrogen-Deuterium Exchange Mass Spectrometry Reveals a Novel Binding Region of a Neutralizing Fully Human Monoclonal Antibody to Anthrax Protective Antigen (2022) (3)
Association of PPP2CA polymorphisms with SLE susceptibility in multiple ethnic groups (2011) (3)
Antibody Reactivity of B Cells in Lupus Patients with Increased Disease Activity and ARID3a Expression (2015) (3)
Polymorphisms in the Hsp 70 gene locus are genetically associated with systemic lupus erythematosus (2010) (3)
Response Using Phage-Display Combinatorial Erythematosus Anti-Smith Antibody Delineation of the Human Systemic Lupus (2000) (3)
FRI0213 RANDOMIZED PLACEBO CONTROLLED TRIAL OF ABATACEPT FOR NON-ORGAN THREATENING SYSTEMIC LUPUS WITH BACKGROUND MEDICATIONS WITHDRAWN (2019) (2)
Editorial for Lindop et al. "long-term Ro60 humoral autoimmunity in primary Sjögren's syndrome is maintained by rapid clonal turnover". (2013) (2)
Unique Serum Immune Phenotypes and Stratification of Oklahoma Native American Rheumatic Disease Patients (2021) (2)
Mock Recruitment for the Study of Antimalarials in an Incomplete Lupus Erythematosus Trial (2019) (2)
Barriers And Motivators for Smoking Cessation in Patients With Systemic Lupus Erythematosus (SLE). (2015) (2)
Roles for Infections in Systemic Lupus Erythematosus Pathogenesis (2011) (2)
OP0140 DYSREGULATED EXPRESSION OF THE LONG NON-CODING RNA, LINC01871, IMPLICATED IN SJÖGREN’S SYNDROME PATHOGENESIS (2020) (2)
Peptide Induction of Systemic Lupus Autoimmunity (2000) (2)
Pre-Clinical Autoimmunity in Lupus Relatives: Self-Reported Questionnaires and Immune Dysregulation Distinguish Relatives Who Develop Incomplete or Classified Lupus From Clinically Unaffected Relatives and Unaffected, Unrelated Individuals (2022) (2)
Infection and Autoimmunity (2007) (2)
Erratum: Vitamin D status and antibody levels to common viruses in pediatric-onset multiple sclerosis (Multiple Sclerosis Journal (2011) 17: 6 (666-671) DOI: 10.1177/1352458511394398) (2011) (2)
Resequencing Study Con ﬁ rms That Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis (2019) (2)
Insufficient Anthrax Lethal Toxin Neutralization Is Associated with Antibody Subclass and Domain Specificity in the Plasma of Anthrax-Vaccinated Individuals (2021) (2)
Insights from Comparison of the Renal and Skin Single Cell Transcriptomes in Lupus Nephritis (2018) (2)
Expanded Autoantibody Profiles for Subsetting of Native American, African American, and European American Patients With Systemic Lupus Erythematosus (2020) (2)
OP0047 GENOME-WIDE ASSOCIATION STUDY OF SJÖGREN’S SYNDROME IDENTIFIES TEN NEW RISK LOCI (2020) (2)
Ancestry-based differences in the immune system are associated with lupus severity (2021) (2)
Author Correction: Tubular cell and keratinocyte single-cell transcriptomics applied to lupus nephritis reveal type I IFN and fibrosis relevant pathways (2019) (2)
P2-323: Memapsin 2 (beta-secretase, BACE) immunization as specific and safe therapy for Alzheimer's disease (2008) (1)
Preclinical SLE (2015) (1)
The Frequency of Rheumatic Disease Autoantibodies in Patients with ADAMTS13-Deficient Thrombotic Thrombocytopenia Purpura (TTP). (2007) (1)
GG-08 Immune repertoire and genetic risk alleles in healthy pediatric populations with autoimmune indicators (2018) (1)
THU0342 The lupus foundation of america rapid evaluation of activity in lupus (LFA-REAL) provides a simple but reliable measurement of sle disease activity (2018) (1)
Lupus and Infections (2019) (1)
Relationship Between a Vitamin D Genetic Risk Score and Autoantibodies Among First-Degree Relatives of Probands With Rheumatoid Arthritis and Systemic Lupus Erythematosus (2022) (1)
OP0167 SUCCESSFUL WITHDRAWAL OF MYCOPHENOLATE MOFETIL IN QUIESCENT SLE: RESULTS FROM A RANDOMIZED TRIAL (2020) (1)
POS0096 SJÖGREN’S DISEASE AND SYSTEMIC LUPUS ERYTHEMATOSUS DDX6-CXCR5 RISK INTERVALS REVEAL COMMON SNPS WITH FUNCTIONAL SIGNIFICANCE IN IMMUNE AND SALIVARY GLAND CELLS (2022) (1)
High incidence of proliferative and membranous nephritis in SLE patients with low proteinuria in the Accelerating Medicines Partnership. (2022) (1)
Multiple TRIM proteins are targets of autoimmune response in lupus and Sjogren's syndrome. (HUM7P.308) (2014) (1)
Disease diagnostics using machine learning of immune receptors (2022) (1)
125 – Preclinical features of lupus (2015) (1)
A differential peripheral blood DNA methylation pattern predictive of radiographic OA progression (2016) (1)
Comparison of autoantibody specificities between traditional and bead-based assays in a large, diverse collection of SLE patients and family members (2012) (1)
GG-05 ATAC-SEQ profiling reveals cell-type specific epigenetic features of systemic lupus erythematosus (SLE) (2016) (1)
Chapter 45 – SLE and Infections (2013) (1)
Genetic load in incomplete lupus erythematosus (2022) (1)
Gram-Positive Bacteria Cell Wall Peptidoglycan Polymers Activate Human Dendritic Cells to Produce IL-23 and IL-1β and Promote TH17 Cell Differentiation (2023) (1)
Single-cell RNA sequencing of skin and kidney cells in lupus nephritis provides insights into pathogenesis and indicates novel potential biomarkers (2018) (1)
Novel shared antibody specificities in anti-Ro/ La antibody negative Sjögren’s Syndrome (2020) (1)
1702 Patients enrolled in the accelerating medicines partnership (AMP) RA/SLE network with isolated renal disease report minimal quality of life impairment on PROMIS-29 compared to patients with extrarenal symptoms (2022) (1)
TLR engagement induces ARID3a in human blood hematopoietic progenitors and modulates IFNα production (2020) (0)
Uranium exposure and systemic lupus erythematosus in a community living near a uranium plant (2013) (0)
ENZYME IMMUNOASSAY VERSUS IMMUNOFLUORESCENCE AMONGST PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS (2019) (0)
Autoantibody-positive healthy individuals display unique immune profiles that regulate autoimmunity (HUM3P.244) (2015) (0)
F.66. SLE Patient Anti-Ro 169 Antibodies Are Associated with Leucopenia and Bind the Surface of Neutrophils (2006) (0)
Neutralizing epitope‐specific antibody responses in Anthrax Vaccine Absorbed (AVA) vaccinated individuals (2008) (0)
Are Patients Who Have Recovered From ADAMTS13-Deficient Thrombotic Thrombocytopenia Purpura (TTP) at Risk for Developing Systemic Lupus Erythematosus (SLE)? (2010) (0)
1401 A Genome Wide Association Scan of SLE genetic risk in a cohort of African-American persons (2022) (0)
Select human anthrax protective antigen (PA) epitope-specific antibodies provide protection from lethal toxin challenge in vitro and in vivo (129.16) (2009) (0)
GG-07 SLE risk haplotypes are associated with development of serologic autoimmunity in healthy individuals (2016) (0)
TCR repertoire analysis of La/SS-B autoantigen-responsive peripheral blood CD4+ T cells using single-cell RT-PCR: a proof of principle case study (P3249) (2013) (0)
Erratum: Genetic associations of LYN with systemic lupus erythematosus (Genes and Immunity (2009) 10 (397-403) DOI: 10.1038/gene.2009.19) (2010) (0)
CS-05 Can systemic lupus erythematosus (SLE) disease activity be consistently scored and interpreted with simple, rapid outcome measures? (2018) (0)
Increased autoimmune disease activity in MRL-lpr mice following influenza infection. (135.21) (2010) (0)
Author Correction: Genome-wide association study identifies Sjögren’s risk loci with functional implications in immune and glandular cells (2023) (0)
Strawberries improve pain symptoms in obese participants with radiographic evidence of knee osteoarthritis (2017) (0)
1107 Immune cell heterogeneity in lupus nephritis kidneys and its relation to histopathological features: lessons from the accelerating medicines partnership (AMP) in SLE Consortium (2022) (0)
717 Enhanced molecular signatures in cutaneous lupus erythematosus patients support distinct pathogenic pathways in African American patients (2020) (0)
Altered adaptive and TNF-superfamily soluble inflammatory mediators mark impending Systemic Lupus Erythematosus disease flare in European-American lupus patients after influenza vaccination (P6282) (2013) (0)
Editorial: Pathogens, Pathobionts, and Autoimmunity (2021) (0)
Clinical and serological features distinguish patients with incomplete lupus classification from systemic lupus erythematosus patients and controls: Clinical and serologic features of incomplete lupus (2017) (0)
Ancestral Differences in Associations Between Disease Manifestations and Serum IFN-α in SLE Patients (2010) (0)
Blood relatives with incomplete lupus are distinguished from unaffected relatives and relatives with classified disease by altered autoantibodies, soluble inflammatory and regulatory mediators, and clinical features (2016) (0)
Early Targets of nRNP Humoral Autoimmunity in Human Systemic Lupus Erythematosus (2011) (0)
Sa.16. Multiple Sclerosis Patients Exhibit a Unique Humoral Response to the Epstein-Barr Virus Nuclear Antigen-1 (2006) (0)
Not H-2 Restricted in Mice IsB Cell Epitope Spreading Is Strain Specific and A Model of Peptide-Induced Lupus Autoimmune (1997) (0)
Heightened preclinical dysregulation of distinct adaptive and renal-associated mediators in patients who develop nephritis as they transition to systemic lupus erythematosus classification (2016) (0)
Bacillus anthracis peptidoglycan alters human M2-like macrophage phenotype and efferocytic function in the presence of human serum (2022) (0)
2009 ACTRIMS ABSTRACTS: Oral Presentations (2009) (0)
Immune and ribosomal gene expression associate with relapse in ADAMTS13-deficient thrombotic thrombocytopenic purpura (P4086) (2013) (0)
GG-07 Regulatory polymorphisms in EMSY gene are associated with autoantibodies in healthy individuals (2018) (0)
Altered innate, adaptive, and TNF-superfamily soluble inflammatory mediators mark impending systemic lupus erythematosus disease flare, while regulatory mediators distinguish lack of impending disease flare in African-American lupus patients (CCR5P.201) (2015) (0)
100 Differing opinions on clinical research between healthcare providers and lupus patients (2019) (0)
Generation of fully human monoclonal antibodies following anthrax vaccine absorbed (AVA) vaccination that provide protection from lethal toxin challenge. (52.15) (2010) (0)
Altered soluble mediator levels and systemic lupus erythematosus-specific Connective Tissue Disease Screening Questionnaire (CSQ) scores differentiate unaffected relatives of lupus patients from healthy individuals with no family history of SLE (CCR4P.214) (2015) (0)
FRI0382 Impact of Treatments on Major Immunologic Pathways in SLE Depends on Type I Interferon Signature: Analysis from Biomarkers of Lupus Disease (BOLD) Study (2014) (0)
1112 Change in urinary biomarkers at three months predicts 1-year treatment response of lupus nephritisbetter than proteinuria (2022) (0)
Deep sequencing reveals a DAP1 regulatory haplotype that potentiates autoimmunity in systemic lupus erythematosus (2020) (0)
Complexed Spliceosomal Autoantigens Target Highly Basic Surface Structures of Anti-Sm Autoantibodies in Systemic Lupus (2002) (0)
902 Loss-of-function variants inSAT1cause X-linked Childhood-onset Systemic Lupus Erythematosus (2022) (0)
Elevated Serum Type I Interferon Activity and Type I Interferon Peripheral Blood Gene Signature In a Subset of Patients with Acquired ADAMTS13-Deficient Thrombotic Thrombocytopenic Purpura. (2010) (0)
Analyses et therapies utilisees dans le cas d'une infection virale latente (2000) (0)
Characterization of the anti-lethal factor (LF) antibody response in Anthrax Vaccine Adsorbed (AVA) individuals (132.15) (2009) (0)
Hematopoietic Progenitor Cells Factor ARID3a in Lupus Patient Differential Expression of the Transcription (2014) (0)
I-03 Dysregulation of T helper-type cytokines and interferons appear during early systemic lupus erythematosus pathogenesis and contribute to clinical disease development (2016) (0)
The role of infections in SLE pathogenesis (2021) (0)
Viral and Genetic Risk Factors for Pediatric Neuromyelitis Optica (P02.114) (2013) (0)
Decreased antigen-specific responses and increased lung pathology in MRL-lpr mice following influenza infection. (92.13) (2010) (0)
ARID3a expression in human hematopoietic stem cells is associated with distinct gene patterns in aged individuals (2020) (0)
ARID3a Defines a Novel Subset of Naïve B Cells in SLE Patients (2021) (0)
Author Correction: Immunologic findings precede rapid lupus flare after transient steroid therapy (2019) (0)
Vaccination and immunotherapy of viral diseases (PP-069) (2010) (0)
Dysregulated long non-coding RNA in Sjögren’s disease impacts both interferon and adaptive immune responses (2022) (0)
Sa.54. Positional Identification of Integrin- αMβ2 (ITGAM) as a Susceptibility Gene for Systematic Lupus Erythematosus (SLE) (2008) (0)
Characterising the autoantibody repertoire in systemic sclerosis following myeloablative haematopoietic stem cell transplantation (2023) (0)
Epstein-Barr virus, CD40 functional mimic, latent membrane protein-1 drives cellular molecular mimicry in the presence of Epstein-Barr virus nuclear antigen-1 in a novel murine model of lupus-like disease (P4063) (2013) (0)
Recognizes the CR 2-C 3 d of a Highly Inhibitory Monoclonal Antibody Receptor Type 2 ( CR 2 ) / CD 21 : Identification Crystallographic Structure of Complement Epitope Mapping Using the X-Ray (2001) (0)
233 Autoantibody-positive healthy individuals constrain T cell pathways to regulate autoimmune disease (2019) (0)
300 Insights from single-cell RNA sequencing of skin and kidney in lupus nephritis (2019) (0)
1706 A model of lupus pathogenesis: anti-EBNA1 heteroantibodies initiate lupus by cross reacting with lupus autoantigens, resulting in lupus autoantibodies and clinical disease (2021) (0)
Dysregulation of T helper-type cytokines appears prior to and concurrent with appearance of autoantibody specificities during early SLE pathogenesis and contributes to prognosis of transition to classified disease (2016) (0)
Author response: Regulatory polymorphisms modulate the expression of HLA class II molecules and promote autoimmunity (2016) (0)
Loss-of-function variants in SAT1 cause X-linked childhood-onset systemic lupus erythematosus (2022) (0)
Chapter 15 – Infection and Autoimmunity (2007) (0)
21 Is lupus nephritis onset delayed in older caucasian females with less aggressive pathology? (2019) (0)
OP0139 FUNCTIONAL EVALUATION OF THE SJÖGREN’S SYNDROME AND SYSTEMIC LUPUS ERYTHEMATOSUS DDX6-CXCR5 RISK INTERVAL (2020) (0)
Comparison of systemic lupus erythematosus and healthy anti-nuclear antibody positive African-Americans reveals distinct differences in CD4+ and CD8+ T cell populations (BA3P.117) (2015) (0)
Author Correction: Immunologic findings precede rapid lupus flare after transient steroid therapy (2019) (0)
Autoantibody Onset Prior to SLE Diagnosis Follows Predictable Patterns of Development (2007) (0)
A Flare Risk Index Informed by Select Immune Mediators in Systemic Lupus Erythematosus (2022) (0)
Infections in early systemic lupus erythematosus pathogenesis (2021) (0)
Top-down Mass Spectrometry Analysis of Human Serum Autoantibody Antigen-Binding Fragments (2019) (0)
THU0263 NOVEL SUBSETS OF SLE PATIENTS ENRICHED FOR RENAL MANIFESTATIONS IDENTIFIED BY CLUSTERING WITH EXPANDED AUTOANTIBODY PROFILES OF NATIVE AMERICAN (NA), AFRICAN AMERICAN (AA), AND EUROPEAN AMERICAN (EA) SLE PATIENTS (2019) (0)
F.84. Influence of Vitamin D Deficiency on Humoral Autoimmunity and Antigen Specific Immunity in Systemic Lupus Erythematosus (2009) (0)
296 Activated stress response genes and perturbation of regulatory pathways in anti-nuclear antibody positive individuals and SLE patients vary by cell type and race in single-cell transcriptomic analyses (2019) (0)
287 African american SLE patients with variable disease activity reveal alterations in signaling pathways and soluble mediators that are more pronounced than european american patients (2019) (0)
Dysregulated immune responses in lupus-prone mice facilitate Th1-cell immunity against influenza A (BA12P.103) (2014) (0)
AB006. A modular analysis approach to studying gene expression in cutaneous lupus erythematosus (2021) (0)
Genes associated with ARID3a expression in B Lymphocytes from Systemic Lupus Erythematosus patients (2018) (0)
Peptidoglycan from Bacillus anthracis Inhibits Human Macrophage Efferocytosis in Part by Reducing Cell Surface Expression of MERTK and TIM-3 (2023) (0)
Sa.9. Common Variants within MECP2 Confer Risk of Systemic Lupus Erythematosus (2008) (0)
Date of Patent : ( 54 ) NON-HUMAN ANIMAL MODEL FOR SYSTEMIC LUPUS ERYTHEMATOSIS ( 75 ) Inventors : (2017) (0)
Determinants of La ( SSB ) Immunodominant and Subdominant T Cell Induction of Autoimmunity by Multivalent and (1999) (0)
SAT0423 Molecular profiles associate with clinical disease activity and inform patient subsetting in adult systemic lupus erythematosus (2018) (0)
C8orf13/BLK association with systemic lupus erythematosus across different ethnicities (136.28) (2009) (0)
S.18. Ribosomal P Autoantibodies are Commonly Present Before SLE Onset and are Directed Against Non-C Terminal Portions of the Protein (2009) (0)
Identification of Novel Sjogren's Syndrome Risk Loci in the Regions of TNFAIP3 and PRDM1 (2015) (0)
Periodontal pathogen exposure facilitates disease activity in Systemic Lupus Erythematosus (2018) (0)
Inflammation in Gram-Positive Sepsis Receptors Are the Key Mediators of γ Anti-Peptidoglycan Antibodies and Fc (2012) (0)
Dysregulation of type II interferon associated mediators precedes autoantibody accumulation and type I interferon elevation and predicts transition to systemic lupus erythematosus classification (BA3P.109) (2015) (0)
FRI0287 Serologic evidence of viral reactivation and increased disease activity in patients with systemic lupus erythematosus (2018) (0)
Delayed antigen‐specific responses and increased disease activity in lupus‐prone mice following influenza infection (2008) (0)
A potential link between immune response to a periodontal bacterium, Aggregatibacter actinomycetemcomintans and Systemic Lupus Erythematosus (2016) (0)
Identification of human effector B lymphocytes that express ARID3a and secrete interferon alpha (2016) (0)
Letter to the Editor (2003) (0)
Cross-reactive humoral epitopes of EF and LF are identified but do not constitute major anthrax toxin neutralization responses following EF and LF vaccination (132.20) (2009) (0)
CLINICAL CHARACTERISTICS OF SYSTEMIC LUPUS ERYTHEMATOSUS WITH MALIGNANT TUMORS (2021) (0)
Enhancer histone-QTLs are enriched on autoimmune risk haplotypes and influence gene expression within chromatin networks (2018) (0)
J. Donald Capra, M.D. (1937–2015) (2015) (0)
Bacillus anthracis cell wall peptidoglycan activates human dendritic cells to promote naïve TH17 and TFH cell differentiation (P4207) (2013) (0)
FRI0270 Identification of novel dysregulated interferon-inducible non-coding rnas in sjÖgren’s syndrome (2018) (0)
The modifying influence of HLA class II DQB1*06:02 on the Streptococcus and clinical phenotype correlation among anti-Ro+ mothers of children with neonatal lupus (2022) (0)
Risk Factors for Transverse Myelitis Compared with Multiple Sclerosis, Neuromyelitis Optica, and Other Neurologic Disorders in Pediatric Patients (P02.121) (2013) (0)
Soluble mediators and clinical features predict transition to systemic lupus erythematosus classification in previously unaffected relatives of SLE patients (HUM3P.243) (2015) (0)
Differential expression of the transcription factor ARID3a in lupus patient hematopoietic progenitors may affect function (BA12P.101) (2014) (0)
OP-BRHE190339 860..868 (2020) (0)
The immune cell landscape in kidneys of patients with lupus nephritis (2019) (0)
Erratum: Complement receptor 2 polymorphisms associated with systemic lupus erythematosus modulate alternative splicing (Genes and Immunity (2009) vol. 10 (457-469) 10.1038/gene.2009.27) (2009) (0)
RNA Surveillance Autoimmunity as a Result of Escape from (2006) (0)
IRF5 Genetic Risk Haplotype Influences Host B Cell Gene Responses to Epstein-Barr Virus (EBV) (49.14) (2009) (0)
Interferon and TNF family soluble inflammatory mediators are detected prior to and increase at Systemic Lupus Erythematosus classification in serum samples from military personnel acquired from the Department of Defense Serum Repository (P3087) (2013) (0)
OR.104. Association of Sjögren's Syndrome (SS) and Systemic Lupus Erythematosus (SLE) with BLK (2008) (0)
Reduced Expression of the DNA-Binding Protein ARID3a, a Mediator of Human Hematopoiesis, in Hematopoietic Progenitors Contributes to Age-Related Transcriptional Changes (2019) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Judith A. James?

Judith A. James is affiliated with the following schools:

University of Oklahoma Health Sciences Center
University of Oklahoma

Judith A. James's Academic­Influence.com Rankings

Why Is Judith A. James Influential?

Judith A. James's Published Works

Published Works

What Schools Are Affiliated With Judith A. James?

Judith A. James's AcademicInfluence.com Rankings